文献速递肿瘤 PET/CT核素与放射性配体治疗

68Ga-pentixafor PET/CT在原醛症合并亚临床库欣综合征中的显像特征

68Ga-pentixafor PET/CT imaging characteristics in primary aldosteronism with coexisting subclinical cushing syndrome: a retrospective cohort study.
PubMed 文献 · EJNMMI Res · 2026-05-07

该回顾性队列纳入52例原发性醛固酮增多症(PA)患者,其中25例合并亚临床库欣综合征(PA-SCS)、27例为单纯PA,比较两组内分泌代谢特征及68Ga-pentixafor PET/CT参数。PA-SCS组肾上腺病灶更大,早期和延迟相病灶对侧比值(LCR)均更高,LCR-10 min鉴别PA-SCS与单纯PA的AUC为0.737。

要点

  • PA-SCS组肾上腺病灶较单纯PA组更大(2.24±0.69 cm vs 1.10±0.56 cm,P<0.0001)。
  • PA-SCS组早期和延迟相LCR均显著高于单纯PA组(P=0.003和P=0.012)。
  • LCR-10 min鉴别PA-SCS与单纯PA的AUC为0.737, cutoff为1.935。

核心结论

  • 68Ga-pentixafor PET/CT可有效鉴别PA-SCS与单纯PA,有助于PA-SCS的早期诊断和临床管理。

研究设计与样本

  • 回顾性队列研究纳入52例接受68Ga-pentixafor PET/CT的原发性醛固酮增多症患者,其中PA-SCS组25例、单纯PA组27例。

主要发现

  • PA-SCS组肾上腺病灶显著大于单纯PA组(2.24±0.69 cm vs 1.10±0.56 cm,P<0.0001)。
  • PA-SCS组早期相LCR显著高于单纯PA组(2.90 [2.01, 3.77] vs 1.41 [1.02, 2.65],P=0.003)。
  • PA-SCS组延迟相LCR显著高于单纯PA组(3.00 [1.80, 4.07] vs 1.26 [1.03, 3.53],P=0.012)。

关键数值与推荐

  • LCR-10 min鉴别PA-SCS与单纯PA的AUC为0.737,cutoff为1.935,灵敏度80.00%,特异度66.67%。

临床怎么用

  • 对原发性醛固酮增多症患者行68Ga-pentixafor PET/CT时,可结合病灶大小及早期相LCR辅助识别合并亚临床库欣综合征者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary aldosteronism (PA) accompanied by subclinical Cushing's syndrome (SCS) complicates both diagnosis and clinical management. This study aimed to investigate the endocrine and metabolic profiles as well as the ⁶⁸Ga‑pentixafor PET/CT imaging features of PA‑SCS, and to evaluate its diagnostic performance for PA‑SCS. RESULTS: A total of 52 patients with primary aldosteronism who underwent 68Ga-pentixafor PET/CT were retrospectively enrolled, including 25 patients with PA complicated by subclinical Cushing's syndrome (PA-SCS) and 27 patients with isolated PA. Adrenal lesions in PA-SCS patients were significantly larger than those in patients with isolated PA (1.10 ± 0.56 cm vs. 2.24 ± 0.69 cm, P < 0.0001). The lesion-to-contralateral ratio (LCR) at both early and delayed phases was significantly higher in the PA-SCS group (10 min: 1.41 [1.02, 2.65] vs. 2.90 [2.01, 3.77], P = 0.003; 40 min: 1.26 [1.03, 3.53] vs. 3.00 [1.80, 4.07], P = 0.012). The LCR-10 min achieved the optimal diagnostic performance for differentiating PA-SCS from isolated PA (AUC = 0.737, cutoff = 1.935, sensitivity = 80.00%, specificity = 66.67%). CONCLUSIONS: ⁶⁸Ga‑pentixafor PET/CT is an effective imaging modality for differentiating PA‑SCS from isolated PA, which complements conventional diagnostic. Methods and optimizes early diagnosis and clinical management of PA‑SCS patients.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Liu S, Zuo R, Li M, et al. 68Ga-pentixafor PET/CT imaging characteristics in primary aldosteronism with coexisting subclinical cushing syndrome: a retrospective cohort study. EJNMMI Res. 2026. PMID: 42096162. doi:10.1186/s13550-026-01444-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。